Published by:

Bayer AG, Leverkusen, Germany
represented by the Management Board:
Werner Baumann, Chairman
Liam Condon, Johannes Dietsch, Hartmut Klusik,
Kemal Malik, Erica Mann, Dieter Weinand

Kaiser-Wilhelm-Allee 1
51373 Leverkusen, Germany
Tel.: +49 (0)214 30-1
E-mail: Inquiries can be sent to or using our contact form.

Entry in the Commercial Register of the Cologne District Court
(Amtsgericht): HRB 48248
Turnover tax ID no.: DE 123659859


Dr. Martin Hobe
Bayer AG
Clinical Pharmacometrics
Building 0431, 308
42113 Wuppertal, Germany
E-mail: martin.hobe(at)

Dr. Jörg Lippert
Bayer AG
Clinical Pharmacometrics
Building 0431, 305
42113 Wuppertal, Germany
E-Mail: joerg.lippert(at)

Concept and Design:
artenreich werbeagentur GmbH, Köln

Development, programming and technical support:
TYPO3 agency
sunzinet AG
Schanzenstraße 23
51063 Köln

This page was last updated 13th of july 2016

April 12, 2017

Two new publications regarding PBPK modeling! : A pregnancy PBPK model has been developed, and evaluated for renally cleared drugs.

» More

March 28, 2017

Published in npj Systems Biology and Applications: Translational learning from clinical studies predicts drug pharmacokinetics across patient populations

» More

December 19, 2016

New publications regarding PBPK modeling: Elderly, Isoniazid, DDI and Diabetes. In addition: A white paper regarding good practices in drug discovery and development

» More

» All News

October 14, 2017

ACoP8 Conference, October 15-18 2017 in Florida

» More

June 25, 2017

14th European ISSX Meeting, June 26-29 2017 in Cologne

» More

June 05, 2017

PAGE Meeting 2017, June 06-09, Budapest, Hungary

» More

» All Events